Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.

BACKGROUND: Preventing graft-versus-host disease (GVHD) by depletion of T lymphocytes from the stem cell graft for transplantation remains controversial, mainly because of the perceived increase in disease recurrence. METHODS: We retrospectively analyzed the outcome of 50 consecutive individuals in...

书目详细资料
Main Authors:	Novitzky, N, Thomas, V, Hale, G, Waldmann, H
格式:	Journal article
语言:	English
出版:	1999

相似书籍

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
由: Novitzky, N, et al.
出版: (1997)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
由: Novitzky, N, et al.
出版: (1997)

In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
由: Willemze, R, et al.
出版: (1992)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
由: Heit, W, et al.
出版: (1986)

T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
由: Jacobs, P, et al.
出版: (1994)

T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
由: Jacobs, P, et al.
出版: (1994)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
由: Hale, G, et al.
出版: (1994)

PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
由: Slavin, S, et al.
出版: (1985)

CAMPATH-1 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AND GRAFT-REJECTION - SUMMARY OF RESULTS FROM A MULTI-CENTRE STUDY
由: Hale, G, et al.
出版: (1988)

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
由: Cobbold, S, et al.
出版: (1986)

Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
由: Apperley, J, et al.
出版: (1986)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
由: Apperley, J, et al.
出版: (1985)

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
由: Kottaridis, P, et al.
出版: (2000)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
由: Hale, G, et al.
出版: (1988)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
由: Linde Dekker, et al.
出版: (2022-06-01)

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
由: Waldmann, H, et al.
出版: (1984)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
由: Novitzky, N, et al.
出版: (2004)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
由: Yue Hu, et al.
出版: (2017-03-01)

Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia Effect
由: Saurabh Kumar Gupta, et al.
出版: (2024-01-01)

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
由: Hale, G, et al.
出版: (1998)

Reduced Efficacy of Mesenchymal Stromal Cells in Preventing Graft-Versus-Host Disease in an in Vivo Model of Haploidentical Bone Marrow Transplant with Leukemia
由: Alberto Oviedo, et al.
出版: (2013-08-01)

Alloreactivity of virus-specific T cellsPossible implication of graft-versus-host disease and graft-versus-leukemia effects
由: Shigeo eFuji, et al.
出版: (2013-10-01)

The graft-versus-leukemia effect in AML
由: Sweeney, C, et al.
出版: (2019)

The Graft-Versus-Leukemia Effect in AML
由: Connor Sweeney, et al.
出版: (2019-11-01)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
由: Hale, G, et al.
出版: (1996)

What can be done to prevent graft versus host disease?
由: Waldmann, H, et al.
出版: (1994)

Reversal of Graft-Versus-Host Disease with Infusion of Autologous Bone Marrow
由: Camillo Ricordi M.D., et al.
出版: (1994-03-01)

The role of pattern-recognition receptors in Graft-versus-host disease and Graft-versus-leukemia after allogeneic stem cell transplantation
由: Simon eHeidegger, et al.
出版: (2014-07-01)

Metabolic instruction of the graft-versus-leukemia immunity
由: Ann-Cathrin Burk, et al.
出版: (2024-03-01)

Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.
由: Slavin, S, et al.
出版: (1985)

Availability of Campath-1 antibodies for bone marrow transplantation.
由: Hale, G, et al.
出版: (1995)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
由: Hale, G, et al.
出版: (1994)

Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.
由: Seiichiro Higo, et al.
出版: (2014-01-01)

Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
由: Kiyomi Mashima, et al.
出版: (2021-01-01)

The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation
由: Teresa Caballero-Velázquez, et al.
出版: (2012-09-01)

Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
由: Eileen Haring, et al.
出版: (2020-07-01)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
由: Jacob Rozmus, et al.
出版: (2022-03-01)

Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
由: Hamblin, M, et al.
出版: (1996)

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.
由: Novitzky, N, et al.
出版: (2005)

Myeloablative conditioning is well tolerated by older patients receiving T-cell depleted grafts
由: Novitzky, N, et al.
出版: (2005)